Cited by 61Peripheral Artery Disease ManagementHealth Systems, Economic Evaluations, Quality of LifeVascular Procedures and Complications

Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease

Open access
Smolderen, K.G., Wang, K., de Pouvourville, G., Brüggenjürgen, B., Röther, J., Zeymer, U., Parhofer, K.G., Steg, P.G. +2 more·2012·European Journal of Vascular and Endovascular Surgery

Abstract

Objectives To obtain Western European perspectives on the economic burden of atherothrombosis in patients with multiple risk factors only (MRF), cerebrovascular disease (CVD), coronary artery disease (CAD), and in the under-evaluated group of patients with peripheral arterial disease (PAD), we examined vascular-related hospitalisation rates and associated costs in France and Germany.Design The prospective REACH Registry enrolled 4693 patients in France, and 5594 patients in Germany (from December 2003 until June 2004).Methods For each country, 2-year rates and costs associated with cardiovascular events and vascular-related hospitalisations were examined for patients with MRF, CVD, CAD, and PAD.Results Two-year hospitalisation costs were highest for patients with PAD (3182.1€ for France; 2724.4€ for Germany) and lowest for the MRF group (749.1€ for France; 503.3€ for Germany). Peripheral revascularizations and amputations were the greatest contributors to costs for all risk groups. Across all PAD subgroups, peripheral procedures constituted approximately half of the 2-year costs.Conclusion Hospitalisation rates and costs associated with atherothrombotic disease in France and Germany are high, especially so for patients with PAD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejvs.2011.09.016

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The mere presence of PAD significantly increases the risk of having atherosclerotic disease in other vascular beds.

    “The mere presence of PAD significantly increases the risk of having atherosclerotic disease in other vascular beds.”

    From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [50]

    The Discussion says patients with PAD tend to have atherosclerotic disease in other arterial beds, supporting an association. It does not establish that PAD itself significantly increases the risk of disease in those beds; the significant increase reported in the Results concerns vascular hospitalisation instead. Page numbers were not available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Approximately 46% to 68% of patients with PAD also had coronary artery disease (CAD) or cerebrovascular disease.

    “Approximately, 46% to 68% of patients with PAD also had coronary artery disease (CAD) or cerebrovascular disease.[48][49][50]”

    From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [50]

    The Risk profile and baseline characteristics section reports polyvascular disease in 13% of French patients and 25% of German patients overall, but does not give the proportion among patients with PAD. I searched for PAD overlap with CAD or cerebrovascular disease and for the 46%–68% range; the retrieved text does not establish that range. (LLM, conf=0.70)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [15]15. Tendera M. How much does Europe invest in the treatment of cardiovascular diseases? Eur Heart J 2006;27:1521e2.

Cited by

Sorted by citations

Authors
Smolderen, K. G., Wang, K., de Pouvourville, G., Brüggenjürgen, B., Röther, J., Zeymer, U., Parhofer, K. G., Steg, P. G., Bhatt, D. L., & Magnuson, E. A.
Affiliations
  • Tilburg University (NL)
  • Saint Luke's Hospital (US)
  • Charité – Universitätsmedizin Berlin (DE)
  • Asklepios Klinik Altona (DE)
  • Stiftung Institut für Herzinfarktforschung (DE)
  • Ludwig-Maximilians-Universität München (DE)
  • Hôpital Bichat-Claude-Bernard (FR)
  • Brigham and Women's Hospital (US)
Corresponding author
Magnuson, E.A.
Venue
European Journal of Vascular and Endovascular Surgery
Publisher
Elsevier BV
Published
2012-02
Volume
43
Issue
2
Pages
198-207
ISSN
1078-5884 (ISSN-L)
OpenAlex
W2093021356
Cited by
61
References
24
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 9 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 6
FWCI
4.25
Type
journal article
Language
en
Open access
Locations
  • European Journal of Vascular and Endovascular Surgery (publishedVersion)
  • Research portal (Tilburg University) (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
Keywords
atherothrombosis, peripheral arterial disease, health care costs, economic burden, multiple risk factors, cerebrovascular disease, coronary artery disease, peripheral revascularization, amputation, France, Germany
MeSH terms
Aged, Aged, 80 and over, Cerebrovascular Disorders, Coronary Artery Disease, Female, Follow-Up Studies, France, Germany, Hospitalization, Humans, Male, Middle Aged, Prospective Studies, Registries, Risk Factors, Thrombosis, Health Care Costs, Cost of Illness, Peripheral Arterial Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review